25 XP   0   0   10

Intracellular Th
Buy, Hold or Sell?

Let's analyse Intracellular Th together

PenkeI guess you are interested in Intracellular Th. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Intracellular Th. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Intracellular Th

I send you an email if I find something interesting about Intracellular Th.

Quick analysis of Intracellular Th (30 sec.)










What can you expect buying and holding a share of Intracellular Th? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$6.11
Expected worth in 1 year
$5.44
How sure are you?
17.5%

+ What do you gain per year?

Total Gains per Share
$-0.67
Return On Investment
-0.9%

For what price can you sell your share?

Current Price per Share
$74.01
Expected price per share
$63.93 - $84.89
How sure are you?
50%

1. Valuation of Intracellular Th (5 min.)




Live pricePrice per Share (EOD)

$74.01

Intrinsic Value Per Share

$-11.23 - $25.65

Total Value Per Share

$-5.12 - $31.76

2. Growth of Intracellular Th (5 min.)




Is Intracellular Th growing?

Current yearPrevious yearGrowGrow %
How rich?$591.4m$714.1m-$107.4m-17.7%

How much money is Intracellular Th making?

Current yearPrevious yearGrowGrow %
Making money-$34.9m-$61.7m$26.7m76.7%
Net Profit Margin-31.6%-119.3%--

How much money comes from the company's main activities?

3. Financial Health of Intracellular Th (5 min.)




What can you expect buying and holding a share of Intracellular Th? (5 min.)

Welcome investor! Intracellular Th's management wants to use your money to grow the business. In return you get a share of Intracellular Th.

What can you expect buying and holding a share of Intracellular Th?

First you should know what it really means to hold a share of Intracellular Th. And how you can make/lose money.

Speculation

The Price per Share of Intracellular Th is $74.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Intracellular Th.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Intracellular Th, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.11. Based on the TTM, the Book Value Change Per Share is $-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $0.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Intracellular Th.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.30-0.4%-0.36-0.5%-0.66-0.9%-0.54-0.7%-0.40-0.5%
Usd Book Value Change Per Share-0.10-0.1%-0.17-0.2%0.620.8%0.140.2%0.140.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-0.1%-0.17-0.2%0.620.8%0.140.2%0.140.2%
Usd Price Per Share71.62-60.30-54.43-39.44-30.81-
Price to Earnings Ratio-60.65--44.55--21.66--20.26--24.86-
Price-to-Total Gains Ratio-748.98--504.68--89.89--147.44--122.00-
Price to Book Ratio11.72-9.64-7.38-7.38-7.42-
Price-to-Total Gains Ratio-748.98--504.68--89.89--147.44--122.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share74.01
Number of shares13
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.170.14
Usd Total Gains Per Share-0.170.14
Gains per Quarter (13 shares)-2.171.84
Gains per Year (13 shares)-8.687.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-9-1907-3
20-17-280154
30-26-3702211
40-35-4602918
50-43-5503725
60-52-6404432
70-61-7305139
80-69-8205946
90-78-9106653
100-87-10007460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%1.044.01.02.2%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%7.033.00.017.5%9.036.01.019.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.044.04.3%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%7.033.00.017.5%10.035.01.021.7%

Fundamentals of Intracellular Th

About Intracellular Th

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-04-11 12:16:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Intracellular Th.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Intracellular Th earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -21.7% means that $-0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Intracellular Th:

  • The MRQ is -21.7%. The company is making a huge loss. -2
  • The TTM is -31.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21.7%TTM-31.6%+9.9%
TTM-31.6%YOY-119.3%+87.7%
TTM-31.6%5Y-3,947.8%+3,916.2%
5Y-3,947.8%10Y-78,130.7%+74,182.9%
1.1.2. Return on Assets

Shows how efficient Intracellular Th is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.9% Return on Assets means that Intracellular Th generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Intracellular Th:

  • The MRQ is -3.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-4.8%+0.9%
TTM-4.8%YOY-7.6%+2.8%
TTM-4.8%5Y-9.5%+4.7%
5Y-9.5%10Y-8.4%-1.2%
1.1.3. Return on Equity

Shows how efficient Intracellular Th is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.8% Return on Equity means Intracellular Th generated $-0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Intracellular Th:

  • The MRQ is -4.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.8%TTM-5.7%+0.9%
TTM-5.7%YOY-8.6%+2.8%
TTM-5.7%5Y-11.1%+5.4%
5Y-11.1%10Y-9.4%-1.7%

1.2. Operating Efficiency of Intracellular Th.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Intracellular Th is operating .

  • Measures how much profit Intracellular Th makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -25.9% means the company generated $-0.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Intracellular Th:

  • The MRQ is -25.9%. The company is operating very inefficient. -2
  • The TTM is -35.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-25.9%TTM-35.9%+10.0%
TTM-35.9%YOY-125.2%+89.3%
TTM-35.9%5Y-4,073.3%+4,037.4%
5Y-4,073.3%10Y-79,145.8%+75,072.5%
1.2.2. Operating Ratio

Measures how efficient Intracellular Th is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.26 means that the operating costs are $1.26 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Intracellular Th:

  • The MRQ is 1.259. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.359. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.259TTM1.359-0.099
TTM1.359YOY2.251-0.892
TTM1.3595Y57.192-55.833
5Y57.19210Y1,535.748-1,478.556

1.3. Liquidity of Intracellular Th.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Intracellular Th is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.41 means the company has $5.41 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Intracellular Th:

  • The MRQ is 5.405. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.168. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.405TTM7.168-1.763
TTM7.168YOY11.054-3.886
TTM7.1685Y10.838-3.670
5Y10.83810Y20.967-10.129
1.3.2. Quick Ratio

Measures if Intracellular Th is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 7.79 means the company can pay off $7.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Intracellular Th:

  • The MRQ is 7.788. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.408. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.788TTM10.408-2.620
TTM10.408YOY17.973-7.566
TTM10.4085Y17.541-7.133
5Y17.54110Y34.823-17.282

1.4. Solvency of Intracellular Th.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Intracellular Th assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Intracellular Th to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.19 means that Intracellular Th assets are financed with 18.8% credit (debt) and the remaining percentage (100% - 18.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Intracellular Th:

  • The MRQ is 0.188. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.158. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.188TTM0.158+0.030
TTM0.158YOY0.113+0.045
TTM0.1585Y0.136+0.022
5Y0.13610Y0.096+0.040
1.4.2. Debt to Equity Ratio

Measures if Intracellular Th is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 23.1% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Intracellular Th:

  • The MRQ is 0.231. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.188. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.231TTM0.188+0.043
TTM0.188YOY0.128+0.060
TTM0.1885Y0.160+0.029
5Y0.16010Y0.112+0.048

2. Market Valuation of Intracellular Th

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Intracellular Th generates.

  • Above 15 is considered overpriced but always compare Intracellular Th to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -60.65 means the investor is paying $-60.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Intracellular Th:

  • The EOD is -62.675. Based on the earnings, the company is expensive. -2
  • The MRQ is -60.651. Based on the earnings, the company is expensive. -2
  • The TTM is -44.547. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-62.675MRQ-60.651-2.024
MRQ-60.651TTM-44.547-16.104
TTM-44.547YOY-21.656-22.891
TTM-44.5475Y-20.264-24.283
5Y-20.26410Y-24.857+4.592
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Intracellular Th:

  • The EOD is -868.659. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -840.608. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -238.358. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-868.659MRQ-840.608-28.052
MRQ-840.608TTM-238.358-602.250
TTM-238.358YOY-21.518-216.840
TTM-238.3585Y-59.646-178.712
5Y-59.64610Y-47.175-12.470
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Intracellular Th is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Intracellular Th:

  • The EOD is 12.114. Based on the equity, the company is expensive. -2
  • The MRQ is 11.723. Based on the equity, the company is expensive. -2
  • The TTM is 9.642. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD12.114MRQ11.723+0.391
MRQ11.723TTM9.642+2.081
TTM9.642YOY7.376+2.266
TTM9.6425Y7.375+2.267
5Y7.37510Y7.419-0.044
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Intracellular Th.

3.1. Institutions holding Intracellular Th

Institutions are holding 98.67% of the shares of Intracellular Th.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc11.83560.063114576944779844.3533
2023-12-31Vanguard Group Inc9.39420.014290943025545776.4941
2023-12-31BlackRock Inc8.46380.01581935446786939.0314
2023-12-31Wasatch Advisors Inc.3.74691.43113627308-175831-4.6233
2023-12-31Bellevue Group AG3.16753.35933066400-103850-3.2758
2023-12-31venBio Select Advisor LLC2.32992.2313225555522555550
2023-12-31State Street Corporation2.29410.00772220850854153.9999
2023-12-31JPMorgan Chase & Co2.1410.0143207261588130.427
2023-12-31Geode Capital Management, LLC2.06780.0152001791907694.7498
2023-12-31Deep Track Capital, LP2.0664.78372000000-600000-23.0769
2023-12-31Amvescap Plc.2.02840.03351963657282751.461
2023-12-31AllianceBernstein L.P.1.86150.04971802027-91814-4.848
2023-12-31Franklin Resources Inc1.83890.05961780160-7904-0.442
2023-12-31Wellington Management Company LLP1.82160.02361763475-52479-2.8899
2023-12-31GW&K Investment Management, LLC1.68191.08741628244-63836-3.7726
2023-12-31Macquarie Group Ltd1.61570.1294156415319677814.3909
2023-12-31ClearBridge Advisors, LLC1.60440.0957155313514953410.6536
2023-09-30Holocene Advisors, LP1.47980.32671432516-263292-15.5261
2023-12-31Pictet Asset Manangement SA1.37880.10541334743-412917-23.6268
2023-12-31T. Rowe Price Associates, Inc.1.30250.0121126089760432892.0433
Total 64.120313.857762073066+3358798+5.4%

3.2. Funds holding Intracellular Th

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Growth Compy Commingled Pl O4.11590.3531398452500
2023-09-30BB Biotech AG Ord3.23426.67353130950-19050-0.6048
2024-02-29Fidelity Growth Company Fund3.06670.3459296882700
2024-02-29Vanguard Total Stock Mkt Idx Inv2.9930.0132897481-7680-0.2644
2024-02-29Vanguard Small Cap Index2.43410.11662356420218390.9355
2024-03-28iShares Russell 2000 ETF2.37030.2425229466585850.3755
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.36730.090213236199670.0731
2024-02-29Vanguard Small Cap Growth Index Inv1.3660.26341322359198621.5249
2024-02-29Fidelity Growth Company K61.02180.37498913600
2023-12-31Macquarie US Small Cap Core Equity1.01780.9441985300805818.9067
2024-01-31Fidelity Small Cap Index0.97910.2575947849151541.6248
2024-02-29Delaware Small Cap Core I0.9450.8639914809-58820-6.0413
2023-12-31Vanguard Explorer Inv0.90390.293187502613144017.6765
2024-03-28iShares Russell 2000 Growth ETF0.83910.4824812357-945-0.1162
2024-02-29ClearBridge Small Cap Growth0.83231.367680572400
2023-12-31ClearBridge Small Cap Growth A0.78871.3125763484-8496-1.1005
2024-02-29Franklin Biotechnology Discv A(acc)USD0.77182.8143747137-113921-13.2304
2024-03-28iShares Biotechnology ETF0.73060.6414707298-1230-0.1736
2024-02-29Fidelity Series Growth Company0.71040.302768770900
2023-12-31Wasatch Small Cap Growth Investor0.69412.099767190300
Total 31.182119.851430186578+68286+0.2%

3.3. Insider Transactions

Insiders are holding 2.511% of the shares of Intracellular Th.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-11Michael HalsteadSELL734565.97
2024-03-11Sharon MatesSELL2056565.21
2024-03-11Lawrence J. HinelineSELL1012165.96
2024-03-07Lawrence J. HinelineSELL1313266.6
2024-03-07Sharon MatesSELL4071266.5
2024-03-07Suresh K DurgamSELL645066.56
2024-02-26Joel S MarcusSELL2632868.68
2024-02-26Lawrence J. HinelineSELL1333769.43
2024-02-26Michael HalsteadSELL790769.53
2024-02-26Sharon MatesSELL2259069.79
2024-01-18Sharon MatesSELL6791765.19
2024-01-16Sharon MatesSELL7536167.25
2024-01-11Michael HalsteadSELL5000066.83
2024-01-02Suresh K. DurgamSELL6228270.6
2023-12-13Suresh K. DurgamSELL2126265
2023-11-06Mark NeumannSELL4239355.63
2023-09-18Sharon MatesSELL5558753.76
2023-08-07Mark NeumannSELL5530058.79
2023-07-17Suresh K DurgamSELL184265
2023-06-14Lawrence J. HinelineSELL8185463.97

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Intracellular Th compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.096-0.167+75%0.615-116%0.141-168%0.145-166%
Book Value Per Share--6.1096.267-3%7.377-17%5.422+13%4.401+39%
Current Ratio--5.4057.168-25%11.054-51%10.838-50%20.967-74%
Debt To Asset Ratio--0.1880.158+19%0.113+66%0.136+38%0.096+96%
Debt To Equity Ratio--0.2310.188+23%0.128+81%0.160+45%0.112+107%
Dividend Per Share----0%-0%-0%-0%
Eps---0.295-0.361+22%-0.662+124%-0.545+85%-0.403+36%
Free Cash Flow Per Share---0.021-0.321+1409%-0.700+3185%-0.524+2360%-0.370+1635%
Free Cash Flow To Equity Per Share--0.010-0.275+2931%0.476-98%0.071-86%0.116-92%
Gross Profit Margin--1.0001.0000%1.576-37%1.115-10%1.058-5%
Intrinsic Value_10Y_max--25.652--------
Intrinsic Value_10Y_min---11.234--------
Intrinsic Value_1Y_max---0.894--------
Intrinsic Value_1Y_min---2.078--------
Intrinsic Value_3Y_max---0.045--------
Intrinsic Value_3Y_min---5.455--------
Intrinsic Value_5Y_max--3.986--------
Intrinsic Value_5Y_min---7.943--------
Market Cap7164700872.000+3%6933331664.0005836990124.000+19%5269215896.000+32%3817640335.600+82%2982775042.800+132%
Net Profit Margin---0.217-0.316+45%-1.193+449%-39.478+18066%-781.307+359418%
Operating Margin---0.259-0.359+39%-1.252+383%-40.733+15610%-791.458+305151%
Operating Ratio--1.2591.359-7%2.251-44%57.192-98%1535.748-100%
Pb Ratio12.114+3%11.7239.642+22%7.376+59%7.375+59%7.419+58%
Pe Ratio-62.675-3%-60.651-44.547-27%-21.656-64%-20.264-67%-24.857-59%
Price Per Share74.010+3%71.62060.295+19%54.430+32%39.436+82%30.812+132%
Price To Free Cash Flow Ratio-868.659-3%-840.608-238.358-72%-21.518-97%-59.646-93%-47.175-94%
Price To Total Gains Ratio-773.977-3%-748.983-504.678-33%-89.886-88%-147.435-80%-121.998-84%
Quick Ratio--7.78810.408-25%17.973-57%17.541-56%34.823-78%
Return On Assets---0.039-0.048+24%-0.076+94%-0.095+143%-0.084+114%
Return On Equity---0.048-0.057+19%-0.086+77%-0.111+130%-0.094+95%
Total Gains Per Share---0.096-0.167+75%0.615-116%0.141-168%0.145-166%
Usd Book Value--591424000.000606701250.000-3%714109750.000-17%524856537.100+13%426052438.200+39%
Usd Book Value Change Per Share---0.096-0.167+75%0.615-116%0.141-168%0.145-166%
Usd Book Value Per Share--6.1096.267-3%7.377-17%5.422+13%4.401+39%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.295-0.361+22%-0.662+124%-0.545+85%-0.403+36%
Usd Free Cash Flow---2062000.000-31117000.000+1409%-67741000.000+3185%-50716221.400+2360%-35784142.825+1635%
Usd Free Cash Flow Per Share---0.021-0.321+1409%-0.700+3185%-0.524+2360%-0.370+1635%
Usd Free Cash Flow To Equity Per Share--0.010-0.275+2931%0.476-98%0.071-86%0.116-92%
Usd Market Cap7164700872.000+3%6933331664.0005836990124.000+19%5269215896.000+32%3817640335.600+82%2982775042.800+132%
Usd Price Per Share74.010+3%71.62060.295+19%54.430+32%39.436+82%30.812+132%
Usd Profit---28579000.000-34918500.000+22%-61711000.000+116%-52268575.300+83%-38754580.025+36%
Usd Revenue--131506000.000115543750.000+14%62283000.000+111%40780312.000+222%20422837.475+544%
Usd Total Gains Per Share---0.096-0.167+75%0.615-116%0.141-168%0.145-166%
 EOD+5 -3MRQTTM+23 -10YOY+17 -175Y+20 -1410Y+20 -14

4.2. Fundamental Score

Let's check the fundamental score of Intracellular Th based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-62.675
Price to Book Ratio (EOD)Between0-112.114
Net Profit Margin (MRQ)Greater than0-0.217
Operating Margin (MRQ)Greater than0-0.259
Quick Ratio (MRQ)Greater than17.788
Current Ratio (MRQ)Greater than15.405
Debt to Asset Ratio (MRQ)Less than10.188
Debt to Equity Ratio (MRQ)Less than10.231
Return on Equity (MRQ)Greater than0.15-0.048
Return on Assets (MRQ)Greater than0.05-0.039
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Intracellular Th based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.190
Ma 20Greater thanMa 5069.791
Ma 50Greater thanMa 10069.380
Ma 100Greater thanMa 20068.158
OpenGreater thanClose75.060
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -4,1901,492-2,698430-2,268933-1,3351,439104



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets728,295
Total Liabilities136,871
Total Stockholder Equity591,424
 As reported
Total Liabilities 136,871
Total Stockholder Equity+ 591,424
Total Assets = 728,295

Assets

Total Assets728,295
Total Current Assets667,799
Long-term Assets60,496
Total Current Assets
Cash And Cash Equivalents 147,767
Short-term Investments 350,174
Net Receivables 114,018
Inventory 11,647
Other Current Assets 42,443
Total Current Assets  (as reported)667,799
Total Current Assets  (calculated)666,049
+/- 1,750
Long-term Assets
Property Plant Equipment 14,582
Long-term Assets Other 45,914
Long-term Assets  (as reported)60,496
Long-term Assets  (calculated)60,496
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities123,545
Long-term Liabilities13,326
Total Stockholder Equity591,424
Total Current Liabilities
Short-term Debt 3,612
Accounts payable 11,452
Other Current Liabilities 108,481
Total Current Liabilities  (as reported)123,545
Total Current Liabilities  (calculated)123,545
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt13,326
Long-term Liabilities  (as reported)13,326
Long-term Liabilities  (calculated)13,326
+/-0
Total Stockholder Equity
Common Stock10
Retained Earnings -1,617,160
Accumulated Other Comprehensive Income 104
Other Stockholders Equity 2,208,470
Total Stockholder Equity (as reported)591,424
Total Stockholder Equity (calculated)591,424
+/-0
Other
Capital Stock10
Cash and Short Term Investments 497,941
Common Stock Shares Outstanding 96,286
Liabilities and Stockholders Equity 728,295
Net Debt -130,829
Net Invested Capital 591,424
Net Working Capital 544,254
Property Plant and Equipment Gross 14,582
Short Long Term Debt Total 16,938



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302011-12-31
> Total Assets 
23,595
0
19,824
4
4
47,336
38,449
146,637
141,343
137,609
131,112
237,128
213,404
513,122
484,104
463,662
447,603
542,572
388,903
372,292
349,540
334,191
471,487
445,639
412,074
385,587
357,206
342,973
309,863
280,523
251,186
481,243
440,931
771,294
717,314
674,489
625,697
556,976
489,922
868,580
811,906
781,999
754,780
722,158
713,602
717,664
728,295
728,295717,664713,602722,158754,780781,999811,906868,580489,922556,976625,697674,489717,314771,294440,931481,243251,186280,523309,863342,973357,206385,587412,074445,639471,487334,191349,540372,292388,903542,572447,603463,662484,104513,122213,404237,128131,112137,609141,343146,63738,44947,3364419,824023,595
   > Total Current Assets 
0
0
0
4
4
47,130
38,249
146,371
141,208
137,481
130,986
236,497
212,611
512,265
483,256
462,859
446,808
541,819
388,200
371,611
348,835
333,435
469,215
443,154
409,661
383,253
355,439
321,128
288,342
259,457
230,324
460,973
418,573
744,866
690,904
649,100
601,303
533,243
467,281
848,342
789,206
759,756
737,957
706,094
698,073
702,425
667,799
667,799702,425698,073706,094737,957759,756789,206848,342467,281533,243601,303649,100690,904744,866418,573460,973230,324259,457288,342321,128355,439383,253409,661443,154469,215333,435348,835371,611388,200541,819446,808462,859483,256512,265212,611236,497130,986137,481141,208146,37138,24947,13044000
       Cash And Cash Equivalents 
13,694
0
15,646
4
4
44,072
35,151
143,618
91,140
68,915
61,325
100,802
71,418
332,828
47,159
37,241
51,973
200,388
48,642
23,598
29,590
52,341
37,790
74,421
69,767
69,777
54,948
64,091
91,763
102,163
107,637
179,593
129,290
300,989
60,046
129,980
121,030
106,126
92,365
129,295
77,235
135,358
148,615
75,727
142,258
99,402
147,767
147,76799,402142,25875,727148,615135,35877,235129,29592,365106,126121,030129,98060,046300,989129,290179,593107,637102,16391,76364,09154,94869,77769,76774,42137,79052,34129,59023,59848,642200,38851,97337,24147,159332,82871,418100,80261,32568,91591,140143,61835,15144,0724415,646013,694
       Short-term Investments 
9,200
0
3,500
0
0
2,000
2,000
2,000
49,355
67,067
68,321
134,424
132,571
177,904
428,041
418,828
390,717
337,406
335,458
344,183
313,038
275,781
426,541
362,584
333,997
306,211
292,583
248,731
193,537
153,271
116,373
269,361
278,469
420,959
597,402
481,985
433,727
371,158
319,968
642,553
600,594
493,383
443,290
462,981
370,596
393,619
350,174
350,174393,619370,596462,981443,290493,383600,594642,553319,968371,158433,727481,985597,402420,959278,469269,361116,373153,271193,537248,731292,583306,211333,997362,584426,541275,781313,038344,183335,458337,406390,717418,828428,041177,904132,571134,42468,32167,06749,3552,0002,0002,000003,50009,200
       Net Receivables 
0
0
0
0
0
251
336
168
219
124
52
3
9
0
31
98
98
1
94
68
62
6
0
0
0
0
0
615
615
351
351
1,351
2,353
7,481
10,765
13,662
15,188
16,934
20,156
32,832
46,976
61,538
75,189
81,545
95,964
102,670
114,018
114,018102,67095,96481,54575,18961,53846,97632,83220,15616,93415,18813,66210,7657,4812,3531,35135135161561500000662689419898310935212421916833625100000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,391
2,335
2,947
7,056
7,579
7,769
8,167
7,948
7,893
25,022
23,597
23,920
28,341
41,895
42,986
11,647
11,64742,98641,89528,34123,92023,59725,0227,8937,9488,1677,7697,5797,0562,9472,3351,3910000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
206
200
266
135
128
125
631
793
857
847
803
794
753
703
681
705
755
2,271
2,485
2,413
2,334
1,768
21,845
21,521
21,066
20,863
20,270
22,357
26,428
26,409
25,388
24,393
23,733
22,641
20,238
22,700
22,243
16,823
16,064
15,529
15,239
60,496
60,49615,23915,52916,06416,82322,24322,70020,23822,64123,73324,39325,38826,40926,42822,35720,27020,86321,06621,52121,8451,7682,3342,4132,4852,27175570568170375379480384785779363112512813526620020600000
       Property Plant Equipment 
67
0
58
0
0
76
68
65
64
57
55
560
722
786
776
731
719
678
628
606
629
680
1,137
1,350
1,275
1,196
1,160
21,230
20,905
20,715
20,512
20,184
22,271
26,342
26,323
25,302
24,307
23,647
22,555
20,152
22,614
22,157
16,737
15,978
15,443
15,153
14,582
14,58215,15315,44315,97816,73722,15722,61420,15222,55523,64724,30725,30226,32326,34222,27120,18420,51220,71520,90521,2301,1601,1961,2751,3501,1376806296066286787197317767867225605557646568760058067
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
36,500
44,700
0
9,200
8,300
0
0
0
21,600
19,500
41,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000041,30019,50021,6000008,3009,200044,70036,50000000000000
       Long-term Assets Other 
0
0
0
0
0
131
132
200
71
71
71
71
71
72
72
72
76
76
76
76
76
76
76
77
79
79
79
86
86
86
86
86
86
86
86
86
86
86
86
86
86
86
86
86
86
86
45,914
45,914868686868686868686868686868686868686867979797776767676767676727272717171717120013213100000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,058
1,058
1,058
1,058
529
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005291,0581,0581,0581,0580000000000000000000000
> Total Liabilities 
5,703
0
18,196
26
26
7,775
6,834
3,912
2,739
3,578
10,557
14,753
9,839
11,268
7,861
10,917
21,640
143,254
13,401
19,265
9,874
14,751
17,050
22,450
21,686
31,962
39,492
54,358
53,094
53,643
56,179
50,794
61,401
61,898
60,454
62,339
72,111
70,219
72,031
75,830
89,709
96,577
98,710
94,548
106,512
116,983
136,871
136,871116,983106,51294,54898,71096,57789,70975,83072,03170,21972,11162,33960,45461,89861,40150,79456,17953,64353,09454,35839,49231,96221,68622,45017,05014,7519,87419,26513,401143,25421,64010,9177,86111,2689,83914,75310,5573,5782,7393,9126,8347,775262618,19605,703
   > Total Current Liabilities 
4,036
0
18,196
26
26
7,775
6,834
3,912
2,739
3,578
10,557
14,593
9,318
10,387
6,264
8,947
19,381
140,690
10,532
16,319
6,963
11,875
14,210
19,653
18,935
29,129
36,299
33,499
32,526
33,373
36,224
31,076
40,243
38,029
36,853
39,702
50,422
49,896
53,356
59,074
70,634
77,410
83,236
79,587
92,080
103,092
123,545
123,545103,09292,08079,58783,23677,41070,63459,07453,35649,89650,42239,70236,85338,02940,24331,07636,22433,37332,52633,49936,29929,12918,93519,65314,21011,8756,96316,31910,532140,69019,3818,9476,26410,3879,31814,59310,5573,5782,7393,9126,8347,775262618,19604,036
       Short-term Debt 
0
0
0
0
9
0
0
0
0
0
0
0
0
0
0
125,000
125,000
125,000
0
0
0
0
0
0
0
0
0
2,873
2,263
2,287
3,187
3,211
3,974
5,267
5,542
5,573
5,595
6,082
6,732
7,636
7,743
7,245
4,567
3,531
3,558
3,584
3,612
3,6123,5843,5583,5314,5677,2457,7437,6366,7326,0825,5955,5735,5425,2673,9743,2113,1872,2872,2632,873000000000125,000125,000125,000000000000090000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125,000
125,000
125,000
0
0
0
0
0
0
0
0
0
2,873
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,873000000000125,000125,000125,000000000000000000
       Accounts payable 
596
0
42
26
26
4,027
3,395
2,143
416
504
2,053
4,574
4,911
705
1,633
1,959
3,890
5,417
3,755
7,158
1,775
4,408
6,174
10,039
5,379
10,453
13,961
8,574
5,633
6,231
7,425
10,994
5,473
8,569
5,502
8,721
15,941
12,031
8,691
11,649
10,749
14,219
10,395
8,441
7,733
10,613
11,452
11,45210,6137,7338,44110,39514,21910,74911,6498,69112,03115,9418,7215,5028,5695,47310,9947,4256,2315,6338,57413,96110,4535,37910,0396,1744,4081,7757,1583,7555,4173,8901,9591,6337054,9114,5742,0535044162,1433,3954,0272626420596
       Other Current Liabilities 
3,440
0
2,982
0
33
3,331
3,439
1,769
2,323
3,074
8,504
10,018
4,407
9,682
4,631
6,987
15,492
10,272
6,778
9,161
5,187
7,467
8,036
9,614
13,556
18,676
22,338
22,052
24,631
24,855
25,612
16,871
30,796
24,192
25,810
25,408
3,846
31,783
37,933
39,789
52,142
55,946
68,274
67,615
80,789
88,895
108,481
108,48188,89580,78967,61568,27455,94652,14239,78937,93331,7833,84625,40825,81024,19230,79616,87125,61224,85524,63122,05222,33818,67613,5569,6148,0367,4675,1879,1616,77810,27215,4926,9874,6319,6824,40710,0188,5043,0742,3231,7693,4393,3313302,98203,440
   > Long-term Liabilities 
0
0
0
26,170
26,170
4,444
3,395
2,143
416
504
2,053
160
521
881
1,597
1,971
2,259
2,564
2,869
2,947
2,911
2,876
2,840
2,797
2,751
2,833
3,192
20,859
20,568
20,270
19,955
19,718
21,158
23,870
23,600
22,637
21,689
20,324
18,675
16,756
19,075
19,167
15,474
14,961
14,432
13,891
13,326
13,32613,89114,43214,96115,47419,16719,07516,75618,67520,32421,68922,63723,60023,87021,15819,71819,95520,27020,56820,8593,1922,8332,7512,7972,8402,8762,9112,9472,8692,5642,2591,9711,5978815211602,0535044162,1433,3954,44426,17026,170000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-9
0
0
0
0
0
0
0
0
0
0
-125,000
-125,000
-125,000
0
0
0
0
0
0
0
0
0
20,859
20,568
20,270
19,955
19,718
21,158
23,870
23,600
22,637
21,689
20,324
18,675
16,756
19,075
19,167
15,474
14,961
14,432
13,891
13,326
13,32613,89114,43214,96115,47419,16719,07516,75618,67520,32421,68922,63723,60023,87021,15819,71819,95520,27020,56820,859000000000-125,000-125,000-125,0000000000000-90000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,058
1,058
1,058
1,058
529
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005291,0581,0581,0581,0580000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,568
20,270
0
0
0
0
0
0
0
0
0
0
0
0
0
14,961
14,432
0
0
0014,43214,961000000000000020,27020,5680000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
521
881
1,597
0
0
0
2,869
0
0
0
2,840
2,797
2,751
2,833
3,192
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000003,1922,8332,7512,7972,8400002,8690001,597881521000000000000
> Total Stockholder Equity
17,892
0
1,628
-22
-22
39,561
31,615
142,725
138,604
134,032
120,555
222,375
203,565
501,854
476,243
452,744
425,963
399,318
375,503
353,027
339,666
319,440
454,437
423,189
390,387
353,625
317,715
288,614
256,768
226,880
195,007
430,448
379,530
709,396
656,860
612,150
553,586
486,756
417,891
792,750
722,197
685,422
656,070
627,610
607,090
600,681
591,424
591,424600,681607,090627,610656,070685,422722,197792,750417,891486,756553,586612,150656,860709,396379,530430,448195,007226,880256,768288,614317,715353,625390,387423,189454,437319,440339,666353,027375,503399,318425,963452,744476,243501,854203,565222,375120,555134,032138,604142,72531,61539,561-22-221,628017,892
   Common Stock
11
0
11
1
1
2
2
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
6
6
6
6
7
7
8
8
8
8
8
8
9
9
9
9
10
10
10
10
10101010999988888877666655555444444444433333221111011
   Retained Earnings Total Equity00-1,564,323-1,521,539-1,477,486-1,433,460-1,379,952-1,293,349-1,221,230-1,135,496-1,058,588-989,844-937,104-876,405-821,221-757,509-710,098-669,516-634,653-597,212-562,376-521,628-480,105-442,729-407,249-377,040-354,170-336,409-309,475-281,990-251,725-220,891-193,049-164,215-132,054-110,543-88,256-73,057-66,641-62,108-57,564-49,524-43-32000
   Accumulated Other Comprehensive Income 
0
0
0
0
-43
-3,236
-3,232
-3,238
-48
-67
-105
-34
-53
-19
-590
-49
60
-171
-317
-292
-316
-220
-799
-1,240
-1,029
-846
-668
-67
232
199
128
-145
1,168
769
481
247
176
94
-364
-3,328
-4,802
-5,496
-4,190
-2,698
-2,268
-1,335
104
104-1,335-2,268-2,698-4,190-5,496-4,802-3,328-364941762474817691,168-145128199232-67-668-846-1,029-1,240-799-220-316-292-317-17160-49-590-19-53-34-105-67-48-3,238-3,232-3,236-430000
   Capital Surplus 
0
0
0
10
10
89,083
89,178
204,830
205,290
207,153
208,912
332,948
335,669
666,084
669,878
673,680
677,624
681,475
685,291
689,723
694,147
696,695
862,480
867,152
871,517
876,094
880,753
885,888
891,184
896,191
904,972
1,188,096
1,199,576
1,585,024
1,593,476
1,601,739
1,611,989
1,622,150
1,639,476
2,089,418
2,106,942
2,124,369
2,137,737
2,151,837
2,173,671
0
0
002,173,6712,151,8372,137,7372,124,3692,106,9422,089,4181,639,4761,622,1501,611,9891,601,7391,593,4761,585,0241,199,5761,188,096904,972896,191891,184885,888880,753876,094871,517867,152862,480696,695694,147689,723685,291681,475677,624673,680669,878666,084335,669332,948208,912207,153205,290204,83089,17889,0831010000
   Treasury Stock00000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
-23
-23
92,319
92,410
208,068
205,290
207,153
208,912
332,948
335,669
666,084
669,878
673,680
677,624
681,475
685,291
689,723
694,147
696,695
862,480
867,152
871,517
876,094
880,753
885,888
891,184
896,191
904,972
1,188,096
1,199,576
1,585,024
1,593,476
1,601,739
1,611,989
1,622,150
1,639,476
2,089,418
2,106,942
2,124,369
2,137,737
2,151,837
2,173,671
2,190,587
2,208,470
2,208,4702,190,5872,173,6712,151,8372,137,7372,124,3692,106,9422,089,4181,639,4761,622,1501,611,9891,601,7391,593,4761,585,0241,199,5761,188,096904,972896,191891,184885,888880,753876,094871,517867,152862,480696,695694,147689,723685,291681,475677,624673,680669,878666,084335,669332,948208,912207,153205,290208,06892,41092,319-23-23000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue462,175
Cost of Revenue-33,745
Gross Profit428,430428,430
 
Operating Income (+$)
Gross Profit428,430
Operating Expense-587,811
Operating Income-159,381-159,381
 
Operating Expense (+$)
Research Development180,142
Selling General Administrative409,864
Selling And Marketing Expenses0
Operating Expense587,811590,006
 
Net Interest Income (+$)
Interest Income20,343
Interest Expense-0
Other Finance Cost-0
Net Interest Income20,343
 
Pretax Income (+$)
Operating Income-159,381
Net Interest Income20,343
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-139,038-179,724
EBIT - interestExpense = -159,381
-139,038
-139,674
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-159,381-139,038
Earnings Before Interest and Taxes (EBITDA)-158,853
 
After tax Income (+$)
Income Before Tax-139,038
Tax Provision-636
Net Income From Continuing Ops-139,674-139,674
Net Income-139,674
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses621,556
Total Other Income/Expenses Net20,343-20,343
 

Technical Analysis of Intracellular Th
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Intracellular Th. The general trend of Intracellular Th is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Intracellular Th's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Intracellular Th.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 84.89.

The bearish price targets are: 70.07 > 64.16 > 63.93.

Tweet this
Intracellular Th Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Intracellular Th. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Intracellular Th Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Intracellular Th. The current macd is 1.60593406.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Intracellular Th price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Intracellular Th. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Intracellular Th price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Intracellular Th Daily Moving Average Convergence/Divergence (MACD) ChartIntracellular Th Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Intracellular Th. The current adx is 23.80.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Intracellular Th shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Intracellular Th Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Intracellular Th. The current sar is 65.76.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Intracellular Th Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Intracellular Th. The current rsi is 57.19. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Intracellular Th Daily Relative Strength Index (RSI) ChartIntracellular Th Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Intracellular Th. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Intracellular Th price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Intracellular Th Daily Stochastic Oscillator ChartIntracellular Th Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Intracellular Th. The current cci is 98.59.

Intracellular Th Daily Commodity Channel Index (CCI) ChartIntracellular Th Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Intracellular Th. The current cmo is 16.06.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Intracellular Th Daily Chande Momentum Oscillator (CMO) ChartIntracellular Th Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Intracellular Th. The current willr is -52.47166626.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Intracellular Th is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Intracellular Th Daily Williams %R ChartIntracellular Th Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Intracellular Th.

Intracellular Th Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Intracellular Th. The current atr is 3.78649667.

Intracellular Th Daily Average True Range (ATR) ChartIntracellular Th Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Intracellular Th. The current obv is 16,122,187.

Intracellular Th Daily On-Balance Volume (OBV) ChartIntracellular Th Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Intracellular Th. The current mfi is 52.45.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Intracellular Th Daily Money Flow Index (MFI) ChartIntracellular Th Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Intracellular Th.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Intracellular Th Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Intracellular Th based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.190
Ma 20Greater thanMa 5069.791
Ma 50Greater thanMa 10069.380
Ma 100Greater thanMa 20068.158
OpenGreater thanClose75.060
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Intracellular Th with someone you think should read this too:
  • Are you bullish or bearish on Intracellular Th? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Intracellular Th? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Intracellular Th

I send you an email if I find something interesting about Intracellular Th.


Comments

How you think about this?

Leave a comment

Stay informed about Intracellular Th.

Receive notifications about Intracellular Th in your mailbox!